|
1
|
Asamura H, Goya T, Koshiishi Y, Sohara Y,
Eguchi K, Mori M, Nakanishi Y, Tsuchiya R, Shimokata K, Inoue H, et
al: A Japanese lung cancer registry study: Prognosis of 13,010
resected lung cancers. J Thorac Oncol. 3:46–52. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Goya T, Asamura H, Yoshimura H, Kato H,
Shimokata K, Tsuchiya R, Sohara Y, Miya T and Miyaoka E; Japanese
Joint Committee of Lung Cancer Registry, : Prognosis of 6644
resected non-small cell lung cancers in Japan: A Japanese lung
cancer registry study. Lung Cancer. 50:227–234. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sawabata N, Miyaoka E, Asamura H,
Nakanishi Y, Eguchi K, Mori M, Nomori H, Fujii Y, Okumura M and
Yokoi K; Japanese Joint Committee for Lung Cancer Registration, :
Japanese lung cancer registry study of 11,663 surgical cases in
2004: Demographic and prognosis changes over decade. J Thorac
Oncol. 6:1229–1235. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kim E, Song C, Kim MY and Kim JS:
Long-term outcomes after salvage radiotherapy for postoperative
locoregionally recurrent non-small-cell lung cancer. Radiat Oncol
J. 35:55–64. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sugimura H, Nichols FC, Yang P, Allen MS,
Cassivi SD, Deschamps C, Williams BA and Pairolero PC: Survival
after recurrent nonsmall-cell lung cancer after complete pulmonary
resection. Ann Thorac Surg. 83:409–418. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hung JJ, Hsu WH, Hsieh CC, Huang BS, Huang
MH, Liu JS and Wu YC: Post-recurrence survival in completely
resected stage I non-small cell lung cancer with local recurrence.
Thorax. 64:192–196. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Endo C, Sakurada A, Notsuda H, Noda M,
Hoshikawa Y, Okada Y and Kondo T: Results of long-term follow-up of
patients with completely resected non-small cell lung cancer. Ann
Thorac Surg. 93:1061–1068. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Socinski MA, Evans T, Gettinger S, Hensing
TA, VanDam Sequist L, Ireland B and Stinchcombe TE: Treatment of
stage IV non-small cell lung cancer: Diagnosis and management of
lung cancer, 3rd ed: American college of chest physicians
evidence-based clinical practice guidelines. Chest. 143 (Suppl
5):e341S–e368S. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mok TS, Lee K and Leung L: Targeting
epidermal growth factor receptor in the management of lung cancer.
Semin Oncol. 41:101–109. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Niibe Y and Hayakawa K: Oligometastases
and oligo-recurrence: The new era of cancer therapy. Jpn J Clin
Oncol. 40:107–111. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Niibe Y and Chang JY: Novel insights of
oligometastases and oligo-recurrence and review of the literature.
Pulm Med. 2012:2610962012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Niibe Y, Chang JY, Onishi H, Salama J,
Hiraki T and Yamashita H: Oligometastases/Oligo-recurrence of lung
cancer. Pulm Med. 2013:4382362013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Niibe Y, Jingu K and Onishi H:
Oligo-recurrence and Sync-oligometastases. J Thorac Oncol.
13:e59–e60. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hishida T, Yoshida J, Aokage K, Nagai K
and Tsuboi M: Postoperative oligo-recurrence of non-small-cell lung
cancer: Clinical features and survival†. Eur J Cardiothorac Surg.
49:847–853. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ashworth A, Rodrigues G, Boldt G and Palma
D: Is there an oligometastatic state in non-small cell lung cancer?
A systematic review of the literature. Lung Cancer. 82:197–203.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Niibe Y, Jingu K and Onishi H: Long-term
outcome of surgery or stereotactic radiotherapy for lung
oligo-recurrence. J Thorac Oncol. 12:e1912017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yamashita H, Niibe Y, Yamamoto T, Katsui
K, Jingu K, Kanazawa S, Terahara A and Nakagawa K: Lung
stereotactic radiotherapy for oligometastases: Comparison of
oligo-recurrence and sync-oligometastases. Jpn J Clin Oncol.
46:687–691. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sekihara K, Hishida T, Yoshida J, Oki T,
Omori T, Katsumata S, Ueda T, Miyoshi T, Goto M, Nakasone S, et al:
Long-term survival outcome after postoperative recurrence of
non-small-cell lung cancer: Who is ‘cured’ from postoperative
recurrence? Eur J Cardiothorac Surg. 52:522–528. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Brooks ED, Verma V, Senan S, De Baere T,
Lu S, Brunelli A and Chang JY; International Association for the
Study of Lung Cancer Advanced Radiation Technology Committee, :
Salvage therapy for locoregional recurrence after stereotactic
ablative radiotherapy for early-stage NSCLC. J Thorac Onco. Nov
9–2019.(Epub ahead of print).
|
|
20
|
Taylor MD, Nagji AS, Bhamidipati CM,
Theodosakis N, Kozower BD, Lau CL and Jones DR: Tumor recurrence
after complete resection for non-small cell lung cancer. Ann Thorac
Surg. 93:1813–1821. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Voltolini L, Paladini P, Luzzi L,
Ghiribelli C, Di Bisceglie M and Gotti G: Iterative surgical
resections for local recurrent and second primary bronchogenic
carcinoma. Eur J Cardiothorac Surg. 18:529–534. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Battafarano RJ, Force SD, Meyers BF, Bell
J, Guthrie TJ, Cooper JD and Patterson GA: Benefits of resection
for metachronous lung cancer. J Thorac Cardiovasc Surg.
127:836–842. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sun B, Brooks ED, Komaki R, Liao Z, Jeter
M, McAleer M, Balter PA, Welsh JD, O'Reilly M, Gomez D, et al:
Long-term outcomes of salvage stereotactic ablative radiotherapy
for isolated lung recurrence of non-small cell lung cancer: A phase
II clinical trial. J Thorac Oncol. 12:983–992. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Saisho S, Yasuda K, Maeda A, Yukawa T,
Okita R, Hirami Y, Shimizu K and Nakata M: Post-recurrence survival
of patients with non-small-cell lung cancer after curative
resection with or without induction/adjuvant chemotherapy. Interact
Cardiovasc Thorac Surg. 16:166–172. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lee K, Kim HR, Kim DK, Kim YH, Park SI,
Choi SH and Han J: Post-recurrence survival analysis of stage I
non-small-cell lung cancer. Asian Cardiovasc Thorac Ann.
25:623–629. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ricardi U, Badellino S and Filippi AR:
Stereotactic radiotherapy for early stage non-small cell lung
cancer. Radiat Oncol J. 33:57–65. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Crabtree TD, Denlinger CE, Meyers BF, El
Naqa I, Zoole J, Krupnick AS, Kreisel D, Patterson GA and Bradley
JD: Stereotactic body radiation therapy versus surgical resection
for stage I non-small cell lung cancer. J Thorac Cardiovasc Surg.
140:377–386. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kimura T, Nagata Y, Eba J, Ozawa S,
Ishikura S, Shibata T, Ito Y, Hiraoka M and Nishimura Y; Radiation
Oncology Study Group of the Japan Clinical Oncology Group, : A
randomized phase III trial of comparing two dose-fractionations
stereotactic body radiotherapy (SBRT) for medically inoperable
stage IA non-small cell lung cancer or small lung lesions
clinically diagnosed as primary lung cancer: Japan clinical
oncology group study JCOG1408 (J-SBRT trial). Jpn J Clin Oncol.
47:277–281. 2017.PubMed/NCBI
|
|
29
|
Rosen JE, Salazar MC, Wang Z, Yu JB,
Decker RH, Kim AW, Detterbeck FC and Boffa DJ: Lobectomy versus
stereotactic body radiotherapy in healthy patients with stage I
lung cancer. J Thorac Cardiovasc Surg. 152:44–54.e9. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chang JY, Liu YH, Zhu Z, Welsh JW, Gomez
DR, Komaki R, Roth JA and Swisher SG: Stereotactic ablative
radiotherapy: A potentially curable approach to early stage
multiple primary lung cancer. Cancer. 119:3402–3410. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chang JY, Senan S, Paul MA, Mehran RJ,
Louie AV, Balter P, Groen HJ, McRae SE, Widder J, Feng L, et al:
Stereotactic ablative radiotherapy versus lobectomy for operable
stage I non-small-cell lung cancer: A pooled analysis of two
randomised trials. Lancet Oncol. 16:630–637. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Onimaru R, Shirato H, Shibata T, Hiraoka
M, Ishikura S, Karasawa K, Matsuo Y, Kokubo M, Shioyama Y,
Matsushita H, et al: Phase I study of stereotactic body radiation
therapy for peripheral T2N0M0 non-small cell lung cancer with
PTV<100 cc using a continual reassessment method (JCOG0702).
Radiother Oncol. 116:276–280. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Verma V, Shostrom VK, Zhen W, Zhang M,
Braunstein SE, Holland J, Hallemeier CL, Harkenrider MM, Iskhanian
A, Jabbour SK, et al: Influence of fractionation scheme and tumor
location on toxicities after stereotactic body radiation therapy
for large (≥5 cm) non-small cell lung cancer: A multi-institutional
analysis. Int J Radiat Oncol Biol Phys. 97:778–785. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Iyengar P, Wardak Z, Gerber DE, Tumati V,
Ahn C, Hughes RS, Dowell JE, Cheedella N, Nedzi L, Westover KD, et
al: Consolidative radiotherapy for limited metastatic
non-small-cell lung cancer: A phase 2 randomized clinical trial.
JAMA Oncol. 4:e1735012018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang HH, Zaorsky NG, Meng MB, Zeng XL,
Deng L, Song YC, Zhuang HQ, Li FT, Zhao LJ, Yuan ZY, et al:
Stereotactic radiation therapy for oligometastases or
oligorecurrence within mediastinal lymph nodes. Oncotarget.
7:18135–18145. 2016.PubMed/NCBI
|
|
36
|
Sobin LH, Gospodarowicz MK and Wittekind
C: International Union Against Cancer (UICC): TNM classification of
malignant tumours. 7th. Wiley-Blackwell; Oxford: 2009
|
|
37
|
Yamashita H, Takahashi W, Haga A, Kida S,
Saotome N and Nakagawa K: Stereotactic body radiotherapy for small
lung tumors in the University of Tokyo hospital. Biomed Res Int.
2014:1365132014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Nakagawa K, Haga A, Kida S, Masutani Y,
Yamashita H, Takahashi W, Sakumi A, Saotome N, Shiraki T, Ohtomo K,
et al: 4D registration and 4D verification of lung tumor position
for stereotactic volumetric modulated arc therapy using
respiratory-correlated cone-beam CT. J Radiat Res. 54:152–156.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Nakagawa K, Haga A, Sakumi A, Yamashita H,
Igaki H, Shiraki T, Ohtomo K, Iwai Y and Yoda K: Impact of
flattening-filter-free techniques on delivery time for lung
stereotactic volumetric modulated arc therapy and image quality of
concurrent kilovoltage cone-beam computed tomography: A preliminary
phantom study. J Radiat Res. 55:200–202. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Timmerman R, Paulus R, Galvin J, Michalski
J, Straube W, Bradley J, Fakiris A, Bezjak A, Videtic G, Johnstone
D, et al: Stereotactic body radiation therapy for medically
inoperable early stage lung cancer. JAMA. 303:1070–1076. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Aoki S, Yamashita H, Haga A, Nawa K, Imae
T, Takahashi W, Abe O and Nakagawa K: Flattening filter-free
technique in volumetric modulated arc therapy for lung stereotactic
body radiotherapy: A clinical comparison with the flattening filter
technique. Oncol Lett. 15:3928–3936. 2018.PubMed/NCBI
|
|
42
|
Aoki S, Yamashita H, Haga A, Ota T,
Takahashi W, Ozaki S, Nawa K, Imae T, Abe O and Nakagawa K:
Stereotactic body radiotherapy for centrally-located lung tumors
with 56 Gy in seven fractions: A retrospective study. Oncol Lett.
16:4498–4506. 2018.PubMed/NCBI
|
|
43
|
Ahnesjö A: Collapsed cone convolution of
radiant energy for photon dose calculation in heterogeneous media.
Med Phys. 16:577–592. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Roesch J, Panje C, Sterzing F, Mantel F,
Nestle U, Andratschke N and Guckenberger M: SBRT for centrally
localized NSCLC-What is too central? Radiat Oncol. 11:1572016.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Meng MB, Wang HH, Zaorsky NG, Sun BS, Zhu
L, Song YC, Li FT, Dong Y, Wang JS, Chen HM, et al: Risk-adapted
stereotactic body radiation therapy for central and ultra-central
early-stage inoperable non-small cell lung cancer. Cancer Sci.
110:3553–3564. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Chang JH, Poon I, Erler D, Zhang L and
Cheung P: The safety and effectiveness of stereotactic body
radiotherapy for central versus ultracentral lung tumors. Radiother
Oncol. 129:277–283. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Chaudhuri AA, Tang C, Binkley MS, Jin M,
Wynne JF, von Eyben R, Hara WY, Trakul N, Loo BW Jr and Diehn M:
Stereotactic ablative radiotherapy (SABR) for treatment of central
and ultra-central lung tumors. Lung Cancer. 89:50–56. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Nagata Y, Hiraoka M, Shibata T, Onishi H,
Kokubo M, Karasawa K, Shioyama Y, Onimaru R, Kozuka T, Kunieda E,
et al: Prospective trial of stereotactic body radiation therapy for
both operable and inoperable T1N0M0 non-small cell lung cancer:
Japan clinical oncology group study JCOG0403. Int J Radiat Oncol
Biol Phys. 93:989–996. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Sapkaroski D, Osborne C and Knight KA: A
review of stereotactic body radiotherapy-is volumetric modulated
arc therapy the answer? J Med Radiat Sci. 62:142–151. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Jiang X, Li T, Liu Y, Zhou L, Xu Y, Zhou X
and Gong Y: Planning analysis for locally advanced lung cancer:
Dosimetric and efficiency comparisons between intensity-modulated
radiotherapy (IMRT), single-arc/partial-arc volumetric modulated
arc therapy (SA/PA-VMAT). Radiat Oncol. 6:1402011. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Yamashita H, Haga A, Takahashi W, Takenaka
R, Imae T, Takenaka S and Nakagawa K: Volumetric modulated arc
therapy for lung stereotactic radiation therapy can achieve high
local control rates. Radiat Oncol. 9:2432014. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Common Terminology Criteria for Adverse
Events (CTCAE) Version 4.0 Published, (v4.03, June 14, 2010).
2009.
|
|
53
|
Kanda Y: Investigation of the freely
available easy-to-use software ‘EZR’ for medical statistics. Bone
Marrow Transplant. 48:452–458. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Dale RG: The application of the
linear-quadratic dose-effect equation to fractionated and
protracted radiotherapy. Br J Radiol. 58:515–528. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Puri V, Crabtree TD, Bell JM, Kreisel D,
Krupnick AS, Broderick S, Patterson GA and Meyers BF: National
cooperative group trials of ‘high-risk’ patients with lung cancer:
Are they truly ‘high-risk’? Ann Thorac Surg. 97:1678–1685. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Ferguson MK, Watson S, Johnson E and
Vigneswaran WT: Predicted postoperative lung function is associated
with all-cause long-term mortality after major lung resection for
cancer. Eur J Cardiothorac Surg. 45:660–664. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Kim GJ, Koshy M, Hanlon AL, Horiba MN,
Edelman MJ, Burrows WM, Battafarano RJ and Suntharalingam M: The
benefit of chemotherapy in esophageal cancer patients with residual
disease after trimodality therapy. Am J Clin Oncol. 39:136–141.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Yukiue H, Tanahashi M, Haneda H, Suzuki E,
Yoshii N and Niwa H: Surgical treatment for recurrent and second
primary lung cancer. Kyobu Geka. 63:944–949. 2010.(In Japanese).
PubMed/NCBI
|
|
59
|
Subotic D, Molins L, Soldatovic I,
Moskovljevic D, Collado L and Hernández J: Completion
pneumonectomy: A valuable option for lung cancer recurrence or new
primaries. World J Surg Oncol. 16:982018. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Takeda A, Sanuki N, Eriguchi T, Enomoto T,
Yokosuka T, Kaneko T, Handa H, Aoki Y, Oku Y and Kunieda E: Salvage
stereotactic ablative irradiation for isolated postsurgical local
recurrence of lung cancer. Ann Thorac Surg. 96:1776–1782. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Nishiyama K, Kodama K, Teshima T and Tada
H: Stereotactic body radiotherapy for second pulmonary nodules
after operation for an initial lung cancer. Jpn J Clin Oncol.
45:947–952. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Kelsey CR, Clough RW and Marks LB: Local
recurrence following initial resection of NSCLC: Salvage is
possible with radiation therapy. Cancer J. 12:283–288. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Gagliasso M, Migliaretti G and Ardissone
F: Assessing the prognostic impact of the international association
for the study of lung cancer proposed definitions of complete,
uncertain, and incomplete resection in non-small cell lung cancer
surgery. Lung Cancer. 111:124–130. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Yoshino I, Yohena T, Kitajima M, Ushijima
C, Nishioka K, Ichinose Y and Sugimachi K: Survival of non-small
cell lung cancer patients with postoperative recurrence at distant
organs. Ann Thorac Cardiovasc Surg. 7:204–209. 2001.PubMed/NCBI
|
|
65
|
Sasaki H, Suzuki A, Tatematsu T, Shitara
M, Hikosaka Y, Okuda K, Moriyama S, Yano M and Fujii Y: Prognosis
of recurrent non-small cell lung cancer following complete
resection. Oncol Lett. 7:1300–1304. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Walsh GL, O'Connor M, Willis KM, Milas M,
Wong RS, Nesbitt JC, Putnam JB Jr, Lee JJ and Roth JA: Is follow-up
of lung cancer patients after resection medically indicated and
cost-effective? Ann Thorac Surg. 60:1563–1570. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Ichinose Y, Kato H, Koike T, Tsuchiya R,
Fujisawa T, Shimizu N, Watanabe Y, Mitsudomi T and Yoshimura M;
Japan Clinical Oncology Group, : Overall survival and local
recurrence of 406 completely resected stage IIIa-N2 non-small cell
lung cancer patients: Questionnaire survey of the Japan clinical
oncology group to plan for clinical trials. Lung Cancer. 34:29–36.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Kagami Y, Nishio M, Narimatsu N, Mjoujin
M, Sakurai T, Hareyama M and Saito A: Radiotherapy for locoregional
recurrent tumors after resection of non-small cell lung cancer.
Lung Cancer. 20:31–35. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Jeremic B and Bamberg M: External beam
radiation therapy for bronchial stump recurrence of non-small-cell
lung cancer after complete resection. Radiother Oncol. 64:251–257.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Timmerman R, McGarry R, Yiannoutsos C,
Papiez L, Tudor K, DeLuca J, Ewing M, Abdulrahman R, DesRosiers C,
Williams M and Fletcher J: Excessive toxicity when treating central
tumors in a phase II study of stereotactic body radiation therapy
for medically inoperable early-stage lung cancer. J Clin Oncol.
24:4833–4839. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Oskan F: The quality of toxicity reporting
and the story of the lung SBRT ‘No-Fly Zone’. Int J Radiat Oncol
Biol Phys. 92:514–515. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Timmerman RD: The quality of toxicity
reporting and the story of the lung SBRT ‘No-Fly Zone’. In Regard
to Oskan. Int J Radiat Oncol Biol Phys. 93:726–727. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Song KJ and Flores RM: Is survival after
sublobar resection vs. lobectomy made equivalent by extent of
lymphadenectomy? Ann Transl Med. 7 (Suppl 6):S1912019.PubMed/NCBI
|
|
74
|
Hattori A, Matsunaga T, Takamochi K, Oh S
and Suzuki K: Locoregional recurrence after segmentectomy for
clinical-T1aN0M0 radiologically solid non-small-cell lung
carcinoma. Eur J Cardiothorac Surg. 51:518–525. 2017.PubMed/NCBI
|
|
75
|
Kim H, Pyo H, Noh JM, Lee W, Park B, Park
HY and Yoo H: Preliminary result of definitive radiotherapy in
patients with non-small cell lung cancer who have underlying
idiopathic pulmonary fibrosis: Comparison between X-ray and proton
therapy. Radiat Oncol. 14:192019. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Yamaguchi S, Ohguri T, Ide S, Aoki T,
Imada H, Yahara K, Narisada H and Korogi Y: Stereotactic body
radiotherapy for lung tumors in patients with subclinical
interstitial lung disease: The potential risk of extensive
radiation pneumonitis. Lung Cancer. 82:260–265. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Glick D, Lyen S, Kandel S, Shapera S, Le
LW, Lindsay P, Wong O, Bezjak A, Brade A, Cho BCJ, et al: Impact of
pretreatment interstitial lung disease on radiation pneumonitis and
survival in patients treated with lung stereotactic body radiation
therapy (SBRT). Clin Lung Cancer. 19:e219–e226. 2018. View Article : Google Scholar : PubMed/NCBI
|
